Epoch Biodesign has secured $12 million in a strategic funding round, with participation from lululemon and KOMPAS VC, among others. The company utilizes enzymatic recycling technology to break down nylon 6,6 waste into its original chemical components, enabling the creation of new, virgin-quality polymers. This investment will support Epoch's global commercialization efforts and expand its industry partnerships.
Amount: $12.0M
